BR
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP)
NASDAQ·Healthcare·Medical - Devices
$444.44
—
Mkt Cap $47.35B
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$225.40
Range $152.88 – $264.60
Implied Upside
-49.3%
Consensus $225.40 vs current $444.44